Author

Maahum Mehdi

Observed name: Mehdi, Maahum

Institution: Medical College of Wisconsin

Observed institution: Medical College of Wisconsin

ORCID: 0000-0002-8562-9347

Observed ORCID: 0000-0002-8562-9347

OpenAlex ID: A5026296352

Outcome comparison between muscle and fasciocutaneous flaps after secondary orthopedic procedures

2022 · Meng Guo, Bejoy Thomas, et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 11

Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast

2021 · Maahum Mehdi, Amanda L Kong, et al. · Journal of Surgical Research · 11

Comprehensive genomic profiling: Does timing matter?

2023 · Bicky Thapa, Gulrayz Ahmed, et al. · Frontiers in Oncology · 10

PDF

Postoperative Interventions in Pediatric Digital Replantation: A Tertiary Referral Center Case Review

2022 · Ellen L. Larson, Margaret W. Lieb, et al. · The Journal Of Hand Surgery · 7

MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC).

2022 · Maahum Mehdi, Samih Z Thalji, et al. · Journal of Clinical Oncology · 7

Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series

2024 · Maahum Mehdi, Aniko Szabo, et al. · Therapeutic Advances in Medical Oncology · 5

Coronary Artery Plaque Assessment by CT Angiogram in Inflammatory Bowel Disease

2023 · Malek Ayoub, Harini Shah, et al. · Inflammatory Bowel Diseases · 3

PDF

ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.

2023 · Maahum Mehdi, Bicky Thapa, et al. · Journal of Clinical Oncology · 1

PDF

Atm Or Chek2 Alterations as Potential Biomarkers of Improved Outcomes with Irinotecan: Real-World Analysis of Advanced Pancreatic Ductal Adenocarcinoma

2023 · Mandana Kamgar, Maahum Mehdi, et al. · SSRN Electronic Journal · 1

Reconstructing the tumor microenvironment to unlock therapeutic options in pancreatic cancer.

2022 · Ben George, Samih Thalji, et al. · Journal of Clinical Oncology · 1

Impact of KRAS alterations in pancreatic ductal adenocarcinoma (PDAC).

2021 · Maahum Mehdi, Mandana Kamgar, et al. · Journal of Clinical Oncology · 1

Beyond BRCAness: ATM pathway defects confer sensitivity to topoisomerase I inhibition

2026 · Mandana Kamgar, Thomas McFall, et al. · Genome Medicine

Su1268 PATIENTS WITH LARYNGOPHARYNGEAL COMPLICATIONS OF REFLUX DISEASE (LPR) EXHIBIT IMPAIRED UES RESPONSE TO SIMULATED ULTRA-SLOW REFLUX EVENTS

2023 · Elliot S. Yu, Patrick Sanvanson, et al. · Gastroenterology

Treatment sequencing for patients with localized duodenal and ampullary adenocarcinoma.

2023 · Abhishek Janardan, Ben George, et al. · Journal of Clinical Oncology

PDF

Tu1140: REFLUX ASSOCIATED IMPEDANCE CHANGE IN THE PROXIMAL ESOPHAGUS IS NOT ACCOMPANIED BY CHANGES IN CONTRACTILITY

2022 · Elliot S. Yu, Maahum Mehdi, et al. · Gastroenterology

Targeted therapy (TT) in patients with KRAS wildtype (WT) pancreatic ductal adenocarcinoma (PDAC) produces durable response.

2022 · Maahum Mehdi, Kaitlin Annunzio, et al. · Journal of Clinical Oncology

S791 Coronary Artery Calcium Score for Assessment of Cardiovascular Risk in Patients With Inflammatory Bowel Disease

2021 · Maahum Mehdi, Jordan Hanrahan, et al. · The American Journal of Gastroenterology

Works count: 19

Citation count: 58

H-index: 5

I10-index: 3